I-2-Chloromandalic Acid CAS 10421-85-9 Assay ≥99.0% Isithombe Esifakiwe Sokuhlanzeka Okuphezulu

2-Chloromandalic Acid CAS 10421-85-9 Assay ≥99.0% High Purity

Incazelo emfushane:

Igama Lekhemikhali: I-2-Chloromandalic Acid

I-CAS: 10421-85-9

Ukubukeka: I-Crystalline Powder Emhlophe noma Engamhlophe

Isivivinyo: ≥99.0%

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezela Komkhiqizi Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
(S)-(+)-2-Chloromandalic Acid CAS: 52950-19-3
(R)-(-)-2-Chloromandalic Acid CAS: 52950-18-2
I-2-Chloromandalic Acid CAS: 10421-85-9
I-Chiral Compounds, Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Chemical Properties:

Igama Lekhemikhali	2-Chloromandelic Acid
Omqondofana	I-DL-2-Chloro Mandelic Acid
Inombolo ye-CAS	10421-85-9
Inombolo yeCAT	I-RF-PI247
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C8H7ClO3
Isisindo samangqamuzana	186.59
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Emhlophe noma Engamhlophe
I-Mandelic Acid	≤0.10%
2-Chlorobenzaldehyde	≤0.10%
Ukuzungezisa okuqondile	-0.1° ~ +0.1°
I-Melting Point	86.0 ~ 92.0℃
Ukungcola Okukodwa	≤0.20%
Ukungcola Okuphelele	≤1.0%
Umswakama (KF)	≤0.50%
Ukulahlekelwa Ekumisweni	≤0.50%
Isivivinyo	≥99.0%
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediate;I-Organic Synthesis

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

I-FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo kanye nabaphakeli be-2-Chloromandalic Acid (CAS: 10421-85-9) enekhwalithi ephezulu, esetshenziswa kabanzi ku-organic synthesis, ukuhlanganiswa kwemithi ephakathi kwemithi kanye ne-Active Pharmaceutical Ingredient (API) synthesis. .